You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
10 June 2026 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) announced on Wednesday that it will stop the phase 3 MOBILIZE study evaluating riliprubart in patients with chronic inflammatory demyelinating polyneuropathy (CIDP...
10 June 2026 - Lynk Pharmaceuticals Co Ltd, a clinical-stage innovative drug development company focused on autoimmune and inflammatory diseases, announced on Tuesday that its partner, Formation Bio, has dosed the first participant in a Phase 1, firs...
10 June 2026 - Verge Labs, a frontier AI lab for human disease biology, and commercial-stage biopharmaceutical company Tenacia Biotechnology announced on Tuesday a strategic platform partnership to advance Tenacia's pipeline for central nervous ...
10 June 2026 - Chinese biotech company Antengene Corporation Limited (SEHK:6996) announced on Tuesday that China's National Medical Products Administration (NMPA) has approved the Investigational New Drug (IND) application for the Phase I ATTRAC...
9 June 2026 - Denmark-based vaccines company Bavarian Nordic A/S (CPH:BAVA) announced on Tuesday that it has been awarded a government contract valued at more than DKK700m to supply its MVA-BN smallpox/mpox vaccine to an undisclosed country during 20...
9 June 2026 - Biopharmaceutical company GSK plc (LON:GSK) (NYSE:GSK) announced on Tuesday that it has entered an agreement to acquire Nuvalent Inc (NASDAQ:NUVL), a Boston-based clinical-stage biopharmaceutical company, in a USD10.6bn transaction aime...